1. Compounding certain ibuprofen oral suspension products under section 503B of the Federal Food, Drug, and Cosmetic Act Publication: Silver Spring, MD : Center for Drug Evaluation and Research, April 2023 Subject(s): Administration, OralDrug Compounding -- methodsDrug Compounding -- standardsDrug IndustryGovernment RegulationIbuprofenLegislation, DrugSuspensionsUnited StatesUnited States. Food and Drug AdministrationUnited States.
